Uncategorized

Key words: Patient information leaflet (PIL), adverse reaction (AR), adverse event (AE), company core safety information (CCSI), summary of product characteristics (SmPC), unsolicited (spontaneous) reports (UR), solicited reports (SR), clinical trials (CT). Pharmacovigilance is a complex system that allows all parties involved in drug circulation to ensure medicinal products...

Dear Сolleagues! It is our great pleasure to invite you to the webinar "5 KEY CHALLENGES OF PHARMACOVIGILANCE IN CHINA" presenting changes in pharmacovigilance practice after China joined ICH. Date: TBD Time: 2:00 PM (CET) Cost of Webinar: FREE Webinar language: in Chinese Webinar organizer: NJ YZ Clinical Trials & Consulting Co.,...

NJ YZ  is participating in the China's Top Domestic & Multinational Clinical Development Leaders Summit in Shanghai from 8th Nov. to 10th Nov. 2017. We will present more information later about this big event in China! For the event website, please check :http://www.chinatrialsevent.com/...

The real-world study conference was held from 29th June to 30th June in Shanghai 2017. In this meeting, Dr.Yuri Zaretsky presented a speech named RWE PHARMACOVIGILANCE: GLOBAL AND LOCAL OUTLOOK. In this speech, Dr. Yuri showed his ideas about PV in real word from global and...

ZM CRO GROUP company President Dr. Yuri Zaretsky has recently started collaborating with Korea Health Industry Development Institute (KHIDI) as an official consultant for Korean pharmaceutical and biotechnology companies - Global Pharma Key Opinion Leader (GPKOL). As GPKOL Dr. Zaretsky is focused on the following issues...